Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...

Полное описание

Библиографические подробности
Главные авторы:	Adam Corey, Nita Johnston
Формат:	Статья
Язык:	English
Опубликовано:	University of Minnesota Libraries Publishing 2016-12-01
Серии:	INNOVATIONS in Pharmacy
Предметы:	Dronedarone, Amiodarone, Medication Use Evaluation, Atrial Fibrillation
Online-ссылка:	https://pubs.lib.umn.edu/index.php/innovations/article/view/480

Схожие документы

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
по: Li Y, и др.
Опубликовано: (2023-12-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
по: Mengran Zhang, и др.
Опубликовано: (2021-08-01)

Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
по: Li-Qin Jiang, и др.
Опубликовано: (2016-05-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
по: Trigo P, и др.
Опубликовано: (2011-12-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
по: M. Yu. Gilyarov, и др.
Опубликовано: (2010-12-01)

Dronedarone for the management of atrial fibrillation
по: Swiss Medical Weekly
Опубликовано: (2011-02-01)

Comparative effects of amiodarone and dronedarone treatments on cardiac function in a rabbit model
по: Worakan Boonhoh, и др.
Опубликовано: (2019-02-01)

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS
по: Ye Xu, и др.
Опубликовано: (2024-10-01)

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics
по: Ying Zhang, и др.
Опубликовано: (2021-08-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
по: Christine Benn Christiansen, и др.
Опубликовано: (2010-03-01)

THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
по: O. V. Gaisenok
Опубликовано: (2016-01-01)

Marked prolongation of QRS duration after initiation of dronedarone therapy
по: Conrad Genz, и др.
Опубликовано: (2014-08-01)

Bioavailability of dronedarone tablets administered with or without food in healthy participants
по: Gerald V. Naccarelli, и др.
Опубликовано: (2024-09-01)

Analysis of a Serious Adverse Reaction of Pulmonary Fibrosis Caused by Dronedarone
по: Yuyan Chen, PM, и др.
Опубликовано: (2024-01-01)

Dronedarone for Recurrent Ventricular Tachycardia: A Real Alternative?
по: Victor Exposito, MD, и др.
Опубликовано: (2012-03-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
по: A. G. Pronin, и др.
Опубликовано: (2020-12-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
по: O. V. Gaisenok
Опубликовано: (2016-01-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
по: Hesham S. Taha, и др.
Опубликовано: (2022-05-01)

Dronedarone-induced photoallergic reaction
по: Levy Amar, PhD, и др.
Опубликовано: (2020-12-01)

Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
по: Niloofar Dadashpour, и др.
Опубликовано: (2015-06-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
по: S. Yu. Martsevich, и др.
Опубликовано: (2016-01-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
по: Abolfath Alizadeh, и др.
Опубликовано: (2022-01-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
по: K. G. Adamyan, и др.
Опубликовано: (2015-11-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
по: Nuri Köse, и др.
Опубликовано: (2022-01-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
по: Shuxin Hou, и др.
Опубликовано: (2016-01-01)

Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial
по: Mohamed Ali Ahmed, и др.
Опубликовано: (2022-09-01)

Transient Bradyarrhythmia A Sole Presentation of Amiodarone-Induced Hypothyroidism
по: Gautam Jesrani, и др.
Опубликовано: (2021-04-01)

Amiodarone pulmonary toxicity: Case report
по: Vasić Nada, и др.
Опубликовано: (2014-01-01)

Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely decompensated heart failure
по: Daisuke Horiuchi, MD, и др.
Опубликовано: (2014-06-01)

SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
по: N P Dorofeeva, и др.
Опубликовано: (2017-03-01)

Late-onset thyrotoxicosis after the cessation of amiodarone
по: Melissa E. Middeldorp, и др.
Опубликовано: (2020-11-01)

Evaluation of Amiodarone Administration in Patients with New-Onset Atrial Fibrillation in Septic Shock
по: Andreea Oprea, и др.
Опубликовано: (2024-09-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
по: D. A. Kuzhel, и др.
Опубликовано: (2016-01-01)

Case Report: Amiodarone-induced multi-organ toxicity
по: Jingrui Yan, и др.
Опубликовано: (2024-07-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
по: V. A. Sulimov, и др.
Опубликовано: (2016-01-01)

Cardiomyocyte-Targeting Peptide to Deliver Amiodarone
по: Maliha Zahid, и др.
Опубликовано: (2023-08-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
по: Kuan-Cheng Lai, и др.
Опубликовано: (2018-05-01)

A case of probable Amiodarone-induced pancreatitis in the treatment of atrial fibrillation: a literature review and case report
по: Christopher J. Mercogliano, и др.
Опубликовано: (2017-11-01)

The incidence of phlebitis development of high concentration of continuous amiodarone infusion with in-line filter compared to the low concentration without in-line filter: a retrospective propensity score-matched analysis
по: Sirichai Cheewatanakornkul, и др.
Опубликовано: (2022-08-01)

Local Use of Hydrogel with Amiodarone in Cardiac Surgery: Experiment and Translation to the Clinic
по: Vladimir Shvartz, и др.
Опубликовано: (2021-03-01)